Brachytherapy
Volume 5, Issue 4 , Pages 244-250 , October 2006

A dosimetric analysis of unstranded seeds versus customized stranded seeds in transperineal interstitial permanent prostate seed brachytherapy

  • Randy V. Heysek

      Affiliations

    • Radiation Oncology Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
    • Central Florida Cancer Institute, Lake Wales, FL
    • Corresponding Author InformationCorresponding author. Radiation Oncology Program, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, MOD-9-RT, Tampa, FL 33612. Tel.: +1-813-745-8424; fax: +1-813-745-7231.
    • ,
  • Clement K. Gwede

      Affiliations

    • Radiation Oncology Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
    • Central Florida Cancer Institute, Lake Wales, FL
    • Health Outcomes and Behavioral Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
    • ,
  • Javier Torres-Roca

      Affiliations

    • Radiation Oncology Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
    • ,
  • Alan Cantor

      Affiliations

    • Biostatistical Core, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
    • ,
  • Stacey Kelley

      Affiliations

    • Health Outcomes and Behavioral Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
    • ,
  • Amarjit S. Saini

      Affiliations

    • Health Outcomes and Behavioral Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
    • ,
  • Julio Pow-Sang

      Affiliations

    • Genital Urinary Oncology Program, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Received 29 June 2006 ,Revised 31 July 2006 ,Accepted 2 August 2006.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106–130
  2. Cooperberg M, Lubeck D, Meng M, et al. The changing face of low risk prostate cancer: Trends in clinical presentation and primary management. J Clin Oncol. 2004;22:2141–2149
  3. O'Leary MP, Baum NH, Blizzard R, et al. 2001 American Urological Association Gallup Survey: Changes in physician practice patterns, satisfaction with urology, and treatment of prostate cancer and erectile dysfunction. J Urol. 2002;68:649–652
  4. Grimm P, Sylvester J. Advances in brachytherapy. Rev Urol. 2004;6(Suppl. 4):537–548
  5. Amling CL, Blute ML, Lerner SE, et al. Influence of prostatic-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a larger referral practice. Mayo Clin Proc. 1998;73:401–406
  6. Sharkey J, Chovnick SD, Behar RJ, et al. Evolution of techniques for ultrasound guided 103 Pd brachytherapy in 950 patients with prostate cancer. Tech Urol. 2000;6:128–134
  7. Grado GL, Larson TR, Balch CS, et al. Actuarial disease free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys. 1998;42:289–298
  8. Horwitz EM, Kmitra RK, Uzzo RG, et al. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent 125I prostate implants. Radiother Oncol. 2003;66:173–179
  9. Lee LN, Stock RG, Stone N. Role of hormonal therapy in the management of intermediate to high risk prostate cancer treated with permanent radioactive seed implantation. Int J Radiat Oncol Biol Phys. 2002;52:444–452
  10. Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: Recommendation of the AAPM Radiation Therapy Committee Task Force Group # 43. Med Phys. 1995;22:209–234
  11. McMillan SC, Bartkowski-Doda L. Measuring bowel elimination. In:  Frank-Stromberg M,  Olsen S editor. Instruments for clinical research in health care. Wilsonville, OR: Jones & Bartlett Inc.; 1997;p. 435–444
  12. Nag S, Erickson B, Parikh S, et al. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 2000;48:779–790
  13. Nag S, Bice W, DeWyngaert K, et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy post implant dosimetric analysis. Int J Radiat Oncol Biol Phys. 2000;46:221–230
  14. Potters L, Cao Y, Calugaru E, et al. A comprehensive review of CT based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2001;50:605–614
  15. Stock RG, Stone NM, Loyc , et al. Post implant dosimetry for I-125 prostate implants: Definitions and factors affecting outcome. Int J Radiat Oncol Biol Phys. 2000;48:899–906
  16. Wallner K, Merrick G, True L, et al. 125I versus 103Pd for low risk prostate cancer: Preliminary PSA outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys. 2003;57:1297–1303
  17. Lee RW, deGuzman AF, Tomlinson SK, et al. Radioactive sources embedded in suture are associated with improved post implant dosimetry in men treated with prostate brachytherapy. Radiother Oncol. 2002;65:123–127
  18. Fagundes HM, Keys R, Wojcik M, et al. Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPID strand: A dosimetric analysis. Brachytherapy. 2004;3:136–140
  19. Eshleman JS, Davis BJ, Pisansky TM, et al. Radioactive seed migration to the chest following transperineal interstitial prostate brachytherapy: Extraprostatic seed placement correlates with migration. Int J Radiat Oncol Biol Phys. 2004;59:419–425
  20. Merrick JS, Butler WM, Dorsey AT. Seed fixity in the periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:215–220
  21. Davis BJ, Bresnahan JF, Stafford SL, et al. Prostate brachytherapy seed migration to a coronary artery found during angiography. J Urol. 2002;168:1103
  22. Tapen EM, Blasko JC, Grimm P, et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1998;42:1063–1067
  23. Fuller DB, Koziol JA. Prostate brachytherapy seed migration and dosimetry: Analysis of potential predictive factors. Brachytherapy. 2003;2:47
  24. Reed DR, Mueller A, Wallner , et al. Rapid strand vs. loose (iodine-125 seeds): A prospective randomized trial. Int J Radiat Oncol Biol Phys. 2004;60(Suppl):461

 Financial disclosure: This study was supported in part by an unrestricted grant from Advanced Care Medical.

PII: S1538-4721(06)00242-X

doi: 10.1016/j.brachy.2006.08.003

Brachytherapy
Volume 5, Issue 4 , Pages 244-250 , October 2006

Article Tools

* Image Usage & Resolution